The oxidative metabolism of catecholamines in the brain: A review

Biochimica et Biophysica Acta - General Subjects

Volumn 1380, Issue 2, 1998, Pages 159-162

  Smythies, John ^a   Galzigna, Lauro ^b  

^a Institute of Neurology   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Aminochrome; Catecholamine auto oxidation; Neuromelanin

Indexed keywords

5 CYSTEINYLDOPAMINE; 5,6 DIHYDROXYINDOLE; CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; DOPAMINE; DOPAMINE DERIVATIVE; DOPAMINE O HYDROQUINONE; DOPAMINE O SEMIQUINONE; DOPAMINE QUINONE; INDOLE DERIVATIVE; NEUROMELANIN; NORADRENALIN; PROSTAGLANDIN SYNTHASE; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; AUTOOXIDATION; BRAIN METABOLISM; CATECHOLAMINE METABOLISM; CHEMICAL STRUCTURE; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; REVIEW;

BRAIN; CATECHOLAMINES; HUMANS; OXIDATION-REDUCTION;

EID: 0032503007     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(97)00131-1     Document Type: Review

References (33)

1. Schayer R.W., Smiley R.L., Kaplan E.H. The metabolism of epinephrine containing isotopic carbon II. J. Biol. Chem. 198:1952;545-551.
2. Axelrod J. O-methylation of epinephrine and other catechols in vitro and in vivo. Science. 126:1957;400-401.
3. Bindoli A., Rigobello M.P., Galzigna L. Toxicology of aminochromes. Toxicol. Lett. 48:1989;3-20.
4. Green D.E., Richter D. Adrenaline and adrenochrome. Biochem. J. 31:1937;596-616.
5. Harley-Mason J. The structure of adrenochrome and related products. Experientia. 4:1948;307-311.
6. Heacock R.A., Powell W.S. Adrenochrome and related compounds. Prog. Med. Chem. 9:1973;276-339.
7. Graham D.G. On the origin and significance of neuromelanin. Arch. Pathol. Lab. Med. 103:1979;359-362.
8. Schayer R.W., Smiley R.L. The metabolism of epinephrine containing isotopic carbon III. J. Biol. Chem. 202:1953;425-430.
9. Goodwin F., Shafritz D., Weissbach H. In vitro polypeptide synthesis in brain. Arch. Biochem. Biophys. 130:1965;183-190.
10. Tse D.C.S., McCreery R.L., Adams R.N. Potential oxidative pathways of brain catecholamines. J. Med. Chem. 19:1976;37-40.
11. Matthews S.B., Henderson A.H., Campbell A.K. The adrenochrome pathway: the major route for adrenalin catabolism by polymorphnuclear leucocytes. J. Mol. Cell. Cardiol. 17:1985;339-348.
12. Fornstedt B., Brun A., Rosengren E., Carlsson A. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J. Neural Trans. I:1989;279-295.
13. Carstam R., Brinck C., Augustsson Hindemith, Rohsman H., Rosengren E. The neuromelanin of the human substantia nigra. Biochim. Biophys. Acta. 1097:1991;152-160.
14. Zhang F., Dryhurst G. Effects of L-cysteine on the oxidative chemistry of dpamine: new reaction pathways of potential relevance to ideopathic Parkinson's disease. J. Med. Chem. 37:1994;1084-1096.
15. Costa C., Bertazzo A., Allegri G.et al. Melanin biosynthesis from dopamine. II. A mass spectrometric and collisional spectroscopic investigation. Pigment Cell Res. 5:1992;122-131.
16. Axelrod J. Enzymatic oxidation of epinephrine to adrenochrome by the salivary gland. Biochim. Biophys. Acta. 85:1964;247-254.
17. Grisham M.B., Perez V.J., Everse J. Neuromelanogneic and cytotoxic properties of canine brain stem peroxidase. J. Neurochem. 48:1987;876-882.
18. Schipper H.M., Kotake Y., Janzen E.G. Catechol oxidation by peroxidase-positive astrocytes in primary culture: an electron spin resonance study. J. Neurosci. 11:1991;2170-2176.
19. Segura-Aguilar J. Peroxidase activity of liver microsomal vitamin D 25-hydroxylase and cytochrome P450 1A2 catalyzes 25-hydroxylation of vitamin D3 and oxidation of dopamine to aminochrome. Biochem. Mol. Med. 58:1996;122-129.
20. Hastings T.G. Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J. Neurochem. 64:1995;919-924.
21. Mattammal M.B., Strong R., Lakshmi V.M.et al. Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease. J. Neurochem. 64:1995;1645-1654.
22. Michel P.P., Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 76:1990;428-435.
23. Cadet J. L, Kahler L.A. Free radical mechanisms in schizophrenia and tardive dyskinesia. Neurosci. Biobehav. Rev. 18:1994;457-467.
24. Ben-Shacher D., Zuk B., Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64:1995;718-723.
25. Lieb K., Andrae J., Reisert I.et al. Neurotoxicity of dopamine and protective effects of the NMDA receptor antagonist AP-5 differ between male and female neurons. Exp. Neurol. 134:1995;222-229.
26. Borchardt R.T. Affinity labelling of catecholamine 0-methyltransferase by the oxidation products of 6-hydroxy dopamine. Mol. Pharmacol. 11:1975;436-449.
27. Smythies J.R. On the function of neuromelanin. Proc. R. Soc. London, Ser. B. 263:1996;491-496.
28. Kötter R. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog. Neurobiol. 44:1994;163-196.
29. Smythies J.R. Oxidative reactions and schizophrenia. Schizophr. Res. 24:1997;357-364.
30. Smythies J.R. The biochemical basis of synaptic plasticity and neural computation: a new theory. Proc. R. Soc. London, Ser. B. 264:1997;575-579.
31. J.A. Cook, D.A. Wink, V. Blount et al., Role of antioxidants in the nitric oxide-elicited inhibition of dopamine uptake in cultured mesencephalic neurons. Insights into potential mechanisms of nitric oxide-mediated neurotoxicity, Neurochem. Int. 28 (1996) 609-617.
32. Axelrod J., Lerner A.B. O-methylation in the conversion of tyrosine to melanin. Biochim. Biophys. Acta. 71:1963;650-655.
33. Bindoli A., Rigobello M.P., Galzigna L. Reduction of adrenochrome by rat liver and brain DT-diaphorase. Free Radic. Res. Comms. 8:1990;295-298.